Noramco™
Thomas Metzger is currently working as the Key Account & Business Development Manager / Country Head Switzerland at CG Pharma & Biotech. Previously, Thomas held roles such as Director Sales, Pharmaceutical & Medical OTC at Noramco™ / Purisys, as well as Head of Business Unit Excipients at Selectchemie AG. With a strong background in sales strategy development, key account management, and cross-functional leadership, Thomas has extensive experience in the pharmaceutical industry. Thomas also holds a degree in Key Account Management from SAWI and has completed specialized programs in business administration and technical management.
This person is not in any offices
Noramco™
Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: – Focusing on high-purity controlled substances – Leveraging intellectual property to devise the most efficient routes to APIs – Providing analytical data, chemical and physical properties, stability studies and regulatory assistance – Formulation friendly particle size grades and extended technical packages – Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply – Supporting world-class supply security of controlled-substances, from schedule I to schedule III